Teva, Granules & Heritage Metformin NDMA Class Action Settlement — $5.55 Million Fund for Diabetes Drug Buyers

vs. Teva, Granules & Heritage

Payout Range

Varies

Deadline

7/10/2026

Time Left

51 days

About this settlement

The Teva, Granules & Heritage Metformin NDMA Class Action Settlement involves a $5.55 million fund for individuals who purchased generic metformin manufactured by these companies between July 20, 2015, and June 2, 2020, following a recall due to NDMA contamination concerns.

Who is eligible

No specific eligibility requirements listed. Review the official settlement terms for complete criteria.

Who is in the settlement class

Individuals in the United States who purchased, paid for, or provided reimbursement for generic versions of metformin-containing drugs manufactured by Teva, Granules, or Heritage between July 20, 2015 and June 2, 2020.

How to claim

This settlement has the following claim path.

Documented losses

Variable (pro rata)

Claimants must provide proof of at least one purchase of metformin.

Documentation required: Upload pharmacy receipt, EOB, refill record, or similar documentation.

How to file

This settlement accepts online and mail claim submissions. Pick whichever is easier.

Mail to
Claims Administrator
A.B. Data, Ltd.
P.O. Box 17300
Milwaukee, WI 53217

Official settlement information

https://openclassactions.com/settlements/teva-pharmaceuticals-metformin-class-action-settlement.php

ClaimHawk is an independent service. Review the official settlement site for legally binding terms.

How ClaimHawk helps you file

  • ✓ Pre-fills your claim form from your encrypted profile
  • ✓ Scans your ID and receipts automatically
  • ✓ Generates the filled claim form as a PDF
  • ✓ Texts you a reminder the week of the deadline
Sign up free →